semaglutide code | C187H291N45O59 | CID 56843331 Ozempic® Semaglutide 1 mg Injection

First approved in 2021, Wegovy is the only FDA-approved semaglutide treatment for weight loss and the medicine that changed how healthcare professionals (HCPs) treat people with obesity as the first weekly GLP-1 option for chronic weight management

The "not localized to the injection site" part is important

Glucagon Control on Food Intake and Energy Balance

Muscle-sparing effect can help preserve lean mass during weight loss

For everyone elseparticularly those paying out-of-pocket or using HSA/FSA fundscompounded tirzepatide remains the more practical choice

These injections, which include a GLP-1 receptor agonist and other helpful ingredients, also offer benefits for heart and metabolic health